Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin unveils generic version of Prozac tablets in US

      Lupin unveils generic version of Prozac tablets in US

      Medical Dialogues Bureau24 Aug 2019 9:45 AM IST
      Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
      Zydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOS

      Zydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOS

      Medical Dialogues Bureau24 Aug 2019 9:35 AM IST
      Research suggests that in women with polycystic ovary syndrome (PCOS), there is increased risk for non-alcoholic fatty liver disease, Zydus Cadila...
      Oklahoma judge to rule in opioid lawsuit against JnJ

      Oklahoma judge to rule in opioid lawsuit against JnJ

      Medical Dialogues Bureau24 Aug 2019 9:10 AM IST
      Lawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
      Allergan, Endo agree to USD 15 million settlement in major opioid case

      Allergan, Endo agree to USD 15 million settlement in major opioid case

      Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
      Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
      Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

      Rationalisation of 294 FDC drugs: CDSCO issues Fresh directions to manufacturers

      Medical Dialogues Bureau23 Aug 2019 12:27 PM IST
      New Delhi: In a move to regularise Fixed Dose Combinations (FDCs), the Central Drugs Standard Control Organization (CDSCO) has notified the process to...
      Glenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancer

      Glenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancer

      Medical Dialogues Bureau23 Aug 2019 11:52 AM IST
      The approved product, Fulvestrant injection is a generic version of AstraZeneca's Faslodex Injection in the same strength, Glenmark Pharma said in a...
      Granules India gets 2 USFDA observations for Chantilly facility

      Granules India gets 2 USFDA observations for Chantilly facility

      Medical Dialogues Bureau23 Aug 2019 11:46 AM IST
      "The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
      Biocon wins European nod for Malaysia insulin facility

      Biocon wins European nod for Malaysia insulin facility

      Medical Dialogues Bureau23 Aug 2019 9:30 AM IST
      Biocon Sdn Bhd, which operates Asia's largest integrated insulin facility, has received the Certificate of Good Manufacturing Practices. The site was...
      AstraZeneca diabetes drug Farxiga meets goal in heart failure trial

      AstraZeneca diabetes drug Farxiga meets goal in heart failure trial

      Medical Dialogues Bureau23 Aug 2019 9:15 AM IST
      Farxiga, already one of AstraZeneca’s top 10 drugs by sales, met the main goal of the so-called DAPA-HF trial, which tested the medicine in addition...
      Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day

      Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day

      Medical Dialogues Bureau23 Aug 2019 9:00 AM IST
      The drug Xenleta, also called lefamulin, works by interfering with the bacteria's ability to replicate. It's the first drug by Nabriva Therapeutics to...
      Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina

      Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina

      Medical Dialogues Bureau22 Aug 2019 10:00 AM IST
      The company has received approval for Ranolazine Extended-Release tablets from the United States Food and Drug Administration (USFDA) to market the...
      Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

      Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

      Medical Dialogues Bureau22 Aug 2019 9:50 AM IST
      "Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo-ALA Co Ltd....
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok